Sign in to view content

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

Geoffrey G. Emerson, MD, PhD, FASRS

Video
Published 2021

Related

Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Episode 32 - Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Cooling Anesthesia for Intravitreal Injection With a Novel Device: Results of the Prospective COOL-2 Study
Daniel L Chao, MD, PhD
Annual Meeting Talks
2020

Category: Socioeconomics

See more